Document is current
Any future updates will be listed below
-
Authors
Cousins, Oliver
Schubert, Julia J.
Chandra, Avinash
Veronese, Mattia
Valkimadi, Polena
Creese, Byron
Khan, Zunera
Arathimos, Ryan
Hampshire, Adam
Rosenzweig, Ivana
Ballard, Clive
Corbett, Anne
Aasland, Dag
Velayudhan, Latha
O’Neill, Michael
Collier, David
Awais, Ramla
Sander, Kerstin
Årstad, Erik
Howes, Oliver
Turkheimer, Federico
Hodges, Angela
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative 2 Joint Undertaking (No 115976)
National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London
MRC Proximity to Discovery: Industry Engagement Fund (External Collaboration, Innovation and Entrepreneurism: Translational Medicine in Exeter 2 (MR/N015746/1)
NIHR Collaboration for Leadership in Applied Health Research and Care South West Peninsula
National Institute for Health Research University College London Hospitals Biomedical Research Centre. A partnership between UCL and University College London Hospitals NHS Foundation Trust
- License Information
-
More Information
Article History
Received: 21 March 2023
Accepted: 31 October 2023
First Online: 21 November 2023
Declarations
:
: Written informed consent for all research participants recruited to PHAGO was obtained according to the Declaration of Helsinki 1975, as revised in 2008. Protocols and procedures contributing to this work complied with the ethical standards of the relevant national and institutional committees on human experimentation and were approved by the London-Bloomsbury ethics committee (reference number 17/LO/1266).
: Not applicable.
: The authors declare no competing interests.
